PETALUMA, Calif., July 16 /PRNewswire/ -- Raydiance, Inc., developer of
the world's first compact, cost-effective and fully software-controlled
UltraShort Pulse (USP) laser system, today announced that it has entered
into a two-year cooperative research and development agreement (CRADA) with
the U.S. Food and Drug Administration (FDA).
Under the agreement, the FDA will utilize Raydiance's USP laser
platform to evaluate the safety and effectiveness of high power
laser-tissue interaction. The collaboration will involve the FDA's Division
of Physics, Office of Science and Engineering Laboratories; Center for
Devices and Radiological Health (CDRH), with hardware, software,
applications and research support provided by Raydiance.
"We are delighted to be collaborating with the FDA on this project,
which represents an important first step in the potential development of
new commercial medical applications that harness the transformational
properties of USP laser technology," said Barry Schuler, Chairman and CEO
of Raydiance, Inc. "We look forward to working with the FDA research team
as partners in this collaborative research."
The FDA's research on the Raydiance USP laser platform will initially
focus on the use, safety and effectiveness of USP lasers in:
-- Ophthalmic applications, including tissue interactions that occur with
ablation of corneal tissues associated with USP laser applications in
refractive surgery and corneal repair;
-- Light Therapy applications, including the kinetic processes of light
therapy that may be employed in new treatments for important diseases
including cancer, cardiovascular disease and diabetes;
-- Gene Transfection applications, including the administration of gene
-- Dental applications, such as the removal of dental composite material
without reducing tooth enamel, the optical inspection of teeth and the
control of decay with non-surgical, non-drilling technologies.
First developed in the 1980s, USP lasers are extremely brief light
pulses of unprecedented power that, unlike continuous wave lasers,
instantly vaporize any material without heat or residual damage to
surrounding areas at very precise scales, down to the micron level. Until
now, most USP systems have been extremely expensive, very large and usable
only by trained photonics experts. This has limited experimentation to
highly-specialized university and government research labs and made
commercialization of meaningful applications nearly impossible.
Today, Raydiance has liberated USP laser technology by combining
advanced fiber and micro-optical components with state-of-the-art software
that is upgraded automatically over the Internet to deliver a powerful,
portable and easy-to-use USP system. Raydiance's business model is to be an
enabling technology platform that allows developers and inventors to apply
the transformational properties of USP technology to a range of
groundbreaking applications quickly, easily and reliably.
About Raydiance, Inc.
Raydiance, Inc. is the developer of the world's first compact, cost-
effective and fully software-controlled UltraShort Pulse (USP) laser
system. This breakthrough technology platform harnesses the incredible
power and precision of these lasers and makes them easily accessible for
the development of revolutionary new applications across a wide range of
industries. Under the guidance of former AOL Chairman and CEO Barry
Schuler, today Raydiance is a fast-growth start-up that is rapidly
validating its vision in the marketplace with early adopters across several
Daniel Miles Delson
Robinson Lerer & Montgomery
SOURCE Raydiance, Inc.